Swami seemed very quiet even by his standards at the AGM. Perhaps he does not like the limelight like DW. I guess he is looking at the big moves. A move into podiatry in the US with an acquisition has been alluded to in the recent past. This sounds ok as it would be profitable but we do not have a licence to sell outside the hospital environment presently . It would have to be a stand alone business selling our product as I would not like to burden us with hundreds more staff with HR issues etc. What I love about PNV is our products are made for $30 and sold for $900..Either way we will break into the podiatry field when we sell outside the hospital system and we will be very price competitive.
PNV Price at posting:
$2.09 Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)